Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the effect of feeding frequency on glucose and insulin metabolism and substrate partitioning.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Maastricht University Medical Center
Collaborators
NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more
NCT06881992 · Tumor Hyperinsulinism (Tumor HI)
NCT07585032 · Insulinoma; Pancreas
NCT07543705 · Glucose Metabolism
NCT02861781 · Obesity, Insulin Resistance, and more
University of Maastricht
Maastricht, Limburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions